Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 25, 2005Expert Opinion on Investigational Drugs

17-AAG: mechanisms of antitumour activity

View Full Paper
Ask AI
Bookmark
Share

Authors

PKPanagiotis A. KonstantinopoulosDana-Farber Cancer InstituteAPAthanasios G. PapavassiliouNational and Kapodistrian University of Athens

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Konstantinopoulos et al. (2005) studied this question.

synapsesocial.com/papers/6a8480f652e6a46b6a68cd62https://doi.org/10.1517/13543784.14.12.1471
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Phase I Pharmacokinetic and Pharmacodynamic Study of 17-Allylamino, 17-Demethoxygeldanamycin in Patients With Advanced Malignancies2005 · 491 citations
  2. 2Altered Hsp90 function in cancer: A unique therapeutic opportunity2004 · 303 citations
  3. 3Hsp90 Regulates a von Hippel Lindau-independent Hypoxia-inducible Factor-1α-degradative Pathway2002 · 669 citations